Trial intelligence / Profile preview

Clinical evaluation of ED99 volumes versus standard volumes of ropivacaine for peripheral nerve blockade

DRKS00004698Phase 4Completed

Sponsor
Medical University of Vienna
Start
Feb 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of ropivacaine in perioperative pain, sponsored by Medical University of Vienna. Primary endpoints: Clinical ED50 of ropivacaine volume for peripheral nerve blockade, Clinical ED95 of ropivacaine volume for peripheral nerve blockade and 1 more. Started Feb 2014; status: completed.

02

Drugs

ropivacaine
03

Conditions

perioperative pain

Beyond the preview

Go deeper on DRKS00004698.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00004698.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call